| Year |
Citation |
Score |
| 2023 |
Wu Y, Chang X, Yang G, Chen L, Wu Q, Gao J, Tian R, Mu W, Gooding JJ, Chen X, Sun S. A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis-targeting Chimeras Enhanced Immunotherapy. Advanced Materials (Deerfield Beach, Fla.). e2210787. PMID 36656993 DOI: 10.1002/adma.202210787 |
0.418 |
|
| 2022 |
Shi D, Wu X, Jian Y, Wang J, Huang C, Mo S, Li Y, Li F, Zhang C, Zhang D, Zhang H, Huang H, Chen X, Wang YA, Lin C, et al. USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer. Nature Communications. 13: 5644. PMID 36163134 DOI: 10.1038/s41467-022-33285-x |
0.469 |
|
| 2022 |
Xiao Y, Li Y, Shi D, Wang X, Dai S, Yang M, Kong L, Chen B, Huang X, Lin C, Liao W, Xu B, Chen X, Wang L, Chen X, et al. MEX3C-mediated decay of SOCS3 mRNA promotes JAK2/STAT3 signaling to facilitate metastasis in hepatocellular carcinoma. Cancer Research. PMID 36112698 DOI: 10.1158/0008-5472.CAN-22-1203 |
0.407 |
|
| 2022 |
Cong VT, Houng JL, Kavallaris M, Chen X, Tilley RD, Gooding JJ. How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells? Chemical Society Reviews. PMID 35938511 DOI: 10.1039/d1cs00707f |
0.426 |
|
| 2022 |
Wang X, Yang T, Yu Z, Liu T, Jin R, Weng L, Bai Y, Gooding JJ, Zhang Y, Chen X. Intelligent Gold Nanoparticles with Oncogenic MicroRNA-dependent Activities to Manipulate Tumorigenic Environments for Synergistic Tumor Therapy. Advanced Materials (Deerfield Beach, Fla.). e2110219. PMID 35170096 DOI: 10.1002/adma.202110219 |
0.387 |
|
| 2021 |
Zhai Q, Chen X, Fei D, Guo X, He X, Zhao W, Shi S, Gooding JJ, Jin F, Jin Y, Li B. Nanorepairers Rescue Inflammation-Induced Mitochondrial Dysfunction in Mesenchymal Stem Cells. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2103839. PMID 34894103 DOI: 10.1002/advs.202103839 |
0.359 |
|
| 2021 |
Han F, Zhao H, Lu J, Yun W, Yang L, Lou Y, Su D, Chen X, Zhang S, Jin H, Li X, Sun J, Huang H, Wang Q, Jiang X. Anti-Tumor Effects of in Acute Myeloid Leukemia. Frontiers in Oncology. 11: 694594. PMID 34150668 DOI: 10.3389/fonc.2021.694594 |
0.355 |
|
| 2021 |
Chen X, Yang X, Yuan P, Jin R, Bao L, Qiu X, Liu S, Liu T, Gooding JJ, Chen W, Liu G, Bai Y, Liu S, Jin Y. Modular immune-homeostatic microparticles promote immune tolerance in mouse autoimmune models. Science Translational Medicine. 13. PMID 33692135 DOI: 10.1126/scitranslmed.aaw9668 |
0.525 |
|
| 2021 |
Li Y, Chen X, Jin R, Chen L, Dang M, Cao H, Dong Y, Cai B, Bai G, Gooding JJ, Liu S, Zou D, Zhang Z, Yang C. Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs. Science Advances. 7. PMID 33627421 DOI: 10.1126/sciadv.abd6740 |
0.377 |
|
| 2020 |
Liu S, Chen X, Bao L, Liu T, Yuan P, Yang X, Qiu X, Gooding JJ, Bai Y, Xiao J, Pu F, Jin Y. Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles. Nature Biomedical Engineering. 4: 1063-1075. PMID 33159193 DOI: 10.1038/s41551-020-00637-1 |
0.371 |
|
| 2019 |
Cao C, Jin R, Wei H, Liu Z, Ni S, Liu GJ, Young HA, Chen X, Liu G. Adaptive in vivo device for theranostics of inflammation: real-time monitoring of interferon-γ and aspirin. Acta Biomaterialia. PMID 31622780 DOI: 10.1016/J.Actbio.2019.10.021 |
0.446 |
|
| 2019 |
Zhou C, Qian W, Li J, Ma J, Chen X, Jiang Z, Cheng L, Duan W, Wang Z, Wu Z, Ma Q, Li X. High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer. Journal of Experimental & Clinical Cancer Research : Cr. 38: 302. PMID 31296258 DOI: 10.1186/S13046-019-1288-7 |
0.309 |
|
| 2019 |
Li J, Qian W, Qin T, Xiao Y, Cheng L, Cao J, Chen X, Ma Q, Wu Z. Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In Vivo. Computational and Structural Biotechnology Journal. 17: 498-506. PMID 31011408 DOI: 10.1016/J.Csbj.2019.03.016 |
0.342 |
|
| 2018 |
Chen X, Jiang Z, Zhou C, Chen K, Li X, Wang Z, Wu Z, Ma J, Ma Q, Duan W. Activation of Nrf2 by Sulforaphane Inhibits High Glucose-Induced Progression of Pancreatic Cancer via AMPK Dependent Signaling. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 50: 1201-1215. PMID 30355942 DOI: 10.1159/000494547 |
0.335 |
|
| 2018 |
Cao C, Jin R, Wei H, Yang WC, Goldys EM, Hutchinson MR, Liu S, Chen X, Yang GF, Liu G. Graphene Oxide Based Recyclable In vivo Device for Amperometric Monitoring of Interferon-γ in Inflammatory Mice. Acs Applied Materials & Interfaces. PMID 30199621 DOI: 10.1021/Acsami.8B13518 |
0.416 |
|
| 2018 |
Jiang Z, Zhou C, Cheng L, Yan B, Chen K, Chen X, Zong L, Lei J, Duan W, Xu Q, Li X, Wang Z, Ma Q, Ma J. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions. Journal of Experimental & Clinical Cancer Research : Cr. 37: 69. PMID 29587800 DOI: 10.1186/S13046-018-0740-4 |
0.342 |
|
| 2018 |
Sun L, Chen K, Jiang Z, Chen X, Ma J, Ma Q, Duan W. Indometacin inhibits the proliferation and activation of human pancreatic stellate cells through the downregulation of COX-2. Oncology Reports. PMID 29565462 DOI: 10.3892/Or.2018.6321 |
0.349 |
|
| 2018 |
Zhou C, Jiang Z, Chen X, Chen K, Wu Z, Ma Q, Li X. Fatostatin inhibits the tumor growth of pancreatic cancer by targeting SREBP1 and lipid synthesis Oncotarget. 9: 905-916. DOI: 10.18632/Oncotarget.24224 |
0.344 |
|
| 2017 |
Zong L, Chen K, Jiang Z, Chen X, Sun L, Ma J, Zhou C, Xu Q, Duan W, Han L, Lei J, Li X, Ma Q, Wang Z. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer. Journal of Experimental & Clinical Cancer Research : Cr. 36: 181. PMID 29228980 DOI: 10.1186/S13046-017-0655-5 |
0.322 |
|
| 2016 |
Lei J, Wu Z, Jiang Z, Li J, Zong L, Chen X, Duan W, Xu Q, Zhang L, Han L, Ma Q, Wang Z, Zhang D. Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells. Oncotarget. PMID 27876704 DOI: 10.18632/Oncotarget.13469 |
0.331 |
|
| 2016 |
Duan W, Chen K, Jiang Z, Chen X, Sun L, Li J, Lei J, Xu Q, Ma J, Li X, Han L, Wang Z, Wu Z, Wang F, Wu E, et al. Desmoplasia Suppression by Metformin-mediated AMPK Activation Inhibits Pancreatic Cancer Progression. Cancer Letters. PMID 27773749 DOI: 10.1016/J.Canlet.2016.10.019 |
0.328 |
|
| 2016 |
Jiang Z, Chen X, Chen K, Sun L, Gao L, Zhou C, Lei M, Duan W, Wang Z, Ma Q, Ma J. YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine. Nutrients. 8. PMID 27669292 DOI: 10.3390/Nu8100546 |
0.349 |
|
| 2016 |
Li W, Zhang L, Chen X, Jiang Z, Zong L, Ma Q. Hyperglycemia Promotes the Epithelial-Mesenchymal Transition of Pancreatic Cancer via Hydrogen Peroxide. Oxidative Medicine and Cellular Longevity. 2016: 5190314. PMID 27433288 DOI: 10.1155/2016/5190314 |
0.33 |
|
| 2016 |
Cao L, Chen X, Xiao X, Ma Q, Li W. Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways. International Journal of Oncology. PMID 27278736 DOI: 10.3892/Ijo.2016.3559 |
0.343 |
|
| 2016 |
Chen X, Liu Z, Parker SG, Zhang X, Gooding JJ, Ru Y, Liu Y, Zhou Y. A Light-Induced Hydrogel Based on Tumor-targeting Mesoporous Silica Nanoparticles as a Theranostic Platform for Sustained Cancer Treatment. Acs Applied Materials & Interfaces. PMID 27265514 DOI: 10.1021/Acsami.6B02562 |
0.429 |
|
| 2016 |
Liu Z, Chen X, Zhang X, Gooding JJ, Zhou Y. Carbon-Quantum-Dots-Loaded Mesoporous Silica Nanocarriers with pH-Switchable Zwitterionic Surface and Enzyme-Responsive Pore-Cap for Targeted Imaging and Drug Delivery to Tumor. Advanced Healthcare Materials. PMID 26987989 DOI: 10.1002/Adhm.201600002 |
0.373 |
|
| 2016 |
Zhang L, Li J, Zong L, Chen X, Chen K, Jiang Z, Nan L, Li X, Li W, Shan T, Ma Q, Ma Z. Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer. Oxidative Medicine and Cellular Longevity. 2016: 1616781. PMID 26881012 DOI: 10.1155/2016/1616781 |
0.335 |
|
| 2016 |
Zhang L, Li J, Ma J, Chen X, Chen K, Jiang Z, Zong L, Yu S, Li X, Xu Q, Lei J, Duan W, Li W, Shan T, Ma Q, et al. The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species. Oxidative Medicine and Cellular Longevity. 2016: 3897250. PMID 26682003 DOI: 10.1155/2016/3897250 |
0.314 |
|
| 2016 |
Zong L, Li J, Chen X, Chen K, Li W, Li X, Zhang L, Duan W, Lei J, Xu Q, Shan T, Ma Q, Sun H. Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer. Oxidative Medicine and Cellular Longevity. 2016: 6815727. PMID 26649143 DOI: 10.1155/2016/6815727 |
0.304 |
|
| 2016 |
Chen X, Ma Q, Wu Z. Arl4C-mediate promotion in the growth and metastasis of pancreatic cancer Pancreatology. 16. DOI: 10.1016/J.Pan.2015.12.113 |
0.308 |
|
| 2015 |
Li W, Cao L, Chen X, Lei J, Ma Q. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway. Oncology Reports. PMID 26707376 DOI: 10.3892/Or.2015.4504 |
0.353 |
|
| 2015 |
Zhang D, Lei J, Ma J, Chen X, Sheng L, Jiang Z, Nan L, Xu Q, Duan W, Wang Z, Li X, Wu Z, Wu E, Ma Q, Huo X. β2-Adrenogenic signaling regulates NNK-induced pancreatic cancer progression via upregulation of HIF-1α. Oncotarget. PMID 26497365 DOI: 10.18632/Oncotarget.5677 |
0.308 |
|
| 2015 |
Li W, Ma Z, Ma J, Li X, Xu Q, Duan W, Chen X, Lv Y, Zhou S, Wu E, Ma Q, Huo X. Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer. Oncotarget. PMID 26439801 DOI: 10.18632/Oncotarget.5045 |
0.342 |
|
| 2015 |
Xu Q, Zong L, Chen X, Jiang Z, Nan L, Li J, Duan W, Lei J, Zhang L, Ma J, Li X, Wang Z, Wu Z, Ma Q, Ma Z. Resveratrol in the treatment of pancreatic cancer. Annals of the New York Academy of Sciences. 1348: 10-9. PMID 26284849 DOI: 10.1111/Nyas.12837 |
0.329 |
|
| 2015 |
Ma J, Duan W, Han S, Lei J, Xu Q, Chen X, Jiang Z, Nan L, Li J, Chen K, Han L, Wang Z, Li X, Wu E, Huo X. Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis. Oncotarget. PMID 25895130 DOI: 10.18632/Oncotarget.3663 |
0.331 |
|
| 2015 |
Xu Q, Wang Z, Chen X, Duan W, Lei J, Zong L, Li X, Sheng L, Ma J, Han L, Li W, Zhang L, Guo K, Ma Z, Wu Z, et al. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer. Oncotarget. 6: 4717-32. PMID 25605248 DOI: 10.18632/Oncotarget.3069 |
0.344 |
|
| 2015 |
Lei J, Fan L, Wei G, Chen X, Duan W, Xu Q, Sheng W, Wang K, Li X. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 36: 3119-26. PMID 25501705 DOI: 10.1007/S13277-014-2948-Z |
0.303 |
|
| 2014 |
Chen X, Cheng X, Soeriyadi AH, Sagnella SM, Lu X, Scott JA, Lowe SB, Kavallaris M, Gooding JJ. Stimuli-responsive functionalized mesoporous silica nanoparticles for drug release in response to various biological stimuli. Biomaterials Science. 2: 121-130. PMID 32481814 DOI: 10.1039/C3Bm60148J |
0.602 |
|
| 2014 |
Wang Z, Li J, Chen X, Duan W, Ma Q, Li X. Disrupting the balance between tumor epithelia and stroma is a possible therapeutic approach for pancreatic cancer. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 20: 2002-6. PMID 25327552 DOI: 10.12659/Msm.892523 |
0.333 |
|
| 2014 |
Xu Q, Ma J, Lei J, Duan W, Sheng L, Chen X, Hu A, Wang Z, Wu Z, Wu E, Ma Q, Li X. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway. Biomed Research International. 2014: 546353. PMID 24812621 DOI: 10.1155/2014/546353 |
0.337 |
|
| 2013 |
Guo K, Freguia S, Dennis PG, Chen X, Donose BC, Keller J, Gooding JJ, Rabaey K. Effects of surface charge and hydrophobicity on anodic biofilm formation, community composition, and current generation in bioelectrochemical systems Environmental Science and Technology. 47: 7563-7570. PMID 23745742 DOI: 10.1021/Es400901U |
0.325 |
|
| 2013 |
Xu Q, Duan W, Lei J, Li R, Sheng L, Chen X, Han L, Ma Q. P-0052Paracrinal Hedgehog Signaling Activates Pancreatic Stellate Cell By Regulating Metabolism In Pancreatic Cancer Annals of Oncology. 24. DOI: 10.1093/Annonc/Mdt203.50 |
0.303 |
|
| 2012 |
Chen X, Cheng X, Justin Gooding J. Detection of trace nitroaromatic isomers using indium tin oxide electrodes modified using β-cyclodextrin and silver nanoparticles Analytical Chemistry. 84: 8557-8563. PMID 22998012 DOI: 10.1021/Ac3014675 |
0.533 |
|
| 2012 |
Chen X, Luais E, Darwish N, Ciampi S, Thordarson P, Gooding JJ. Studies on the effect of solvents on self-assembled monolayers formed from organophosphonic acids on indium tin oxide Langmuir. 28: 9487-9495. PMID 22621243 DOI: 10.1021/La3010129 |
0.664 |
|
| 2012 |
Chen X, Cheng X, Gooding JJ. Multifunctional modified silver nanoparticles as ion and pH sensors in aqueous solution Analyst. 137: 2338-2343. PMID 22453116 DOI: 10.1039/C2An35147A |
0.592 |
|
| 2011 |
Chen X, Gooding J, Zou G, Su W, Zhang Q. Polydiacetylene vesicles containing αα-cyclodextrin and azobenzene as photocontrolled nanocarriers. Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry. 12: 2714-8. PMID 21898752 DOI: 10.1002/Cphc.201100412 |
0.314 |
|
| 2011 |
Chen X, Rao J, Wang J, Gooding JJ, Zou G, Zhang Q. A facile enantioseparation for amino acids enantiomers using β-cyclodextrins functionalized Fe3O4 nanospheres. Chemical Communications (Cambridge, England). 47: 10317-9. PMID 21850300 DOI: 10.1039/C1Cc13734D |
0.335 |
|
| Show low-probability matches. |